Resibufogenin targets the atp1a1 signaling cascade to induce g2/m phase arrest and inhibit invasion in glioma

HIGHLIGHTS

• who: GBM et al. from the Department of Neurosurgery, Qilu Hospital, Cheeloo College of Medicine and Institute of Brain and Brain-Inspired Science, Shandong University, Jinan, China, Shandong Key Laboratory of Brain Function Remodeling and Jinan Microecological have published the Article: Resibufogenin Targets the ATP1A1 Signaling Cascade to Induce G2/M Phase Arrest and Inhibit Invasion in Glioma, in the Journal: (JOURNAL)
• what: Taken together, the study shows that when RB binds to ATP1A1, Na+-K+-ATPase is activated as a receptor, accompanied by activation of the intracellular MAPK/ERK pathway and inhibition of the . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.